Table 1 Correlation of TDRKH-AS1 with clinicopathological characteristics in The Cancer Genome Atlas (TCGA) cohort
From: LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis
Characteristic | Low expression of TDRKH-AS1 | High expression of TDRKH-AS1 | P |
|---|---|---|---|
n | 541 | 542 | |
T stage, n (%) | 0.087 | ||
T1 | 155 (14.4%) | 122 (11.3%) | |
T2 | 298 (27.6%) | 331 (30.6%) | |
T3 | 67 (6.2%) | 72 (6.7%) | |
T4 | 20 (1.9%) | 15 (1.4%) | |
N stage, n (%) | 0.892 | ||
N0 | 254 (23.9%) | 260 (24.4%) | |
N1 | 179 (16.8%) | 179 (16.8%) | |
N2 | 62 (5.8%) | 54 (5.1%) | |
N3 | 38 (3.6%) | 38 (3.6%) | |
M stage, n (%) | 0.031* | ||
M0 | 468 (50.8%) | 434 (47.1%) | |
M1 | 5 (0.5%) | 15 (1.6%) | |
Age, meidan (IQR) | 58 (49, 67) | 58 (48.25, 67) | 0.580 |